USANA Health Sciences

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

USANA Health Sciences addresses challenges, eyes growth through cost management

USANA Health Sciences navigated a challenging operating environment by focusing on cost management, product demand trends, and growth strategies. Despite facing headwinds in China and Southeast Asia, the company remains resilient and poised for opportunities in new markets and acquisitions.

USANA Health Sciences reports solid Q1 results amid global challenges

USANA Health Sciences delivered strong Q1 results amidst global challenges, driven by robust demand for health products.
Strategic leadership transition and focus on cost management position the company for sustained growth and operational efficiency.
Opportunities in China market, new market launches, and enhanced customer engagement strategies offer avenues for future expansion.

USANA Health Sciences exceeds Q2 expectations, eyes India expansion

USANA Health Sciences delivered strong Q2 results with a focus on sustainable growth strategies and expansion into new markets. Challenges include tough year-over-year comparisons and cash flow impact from accrued liabilities.

USANA Health Sciences addresses challenges, eyes India expansion for growth

USANA Health Sciences navigated challenges in Q3 2023 with a focus on addressing operational hurdles and driving growth through strategic initiatives. The company's restructuring and expansion into India signal a commitment to long-term success and capitalizing on emerging opportunities.

USANA Health Sciences exceeds Q4 expectations, eyes global growth

USANA Health Sciences delivered strong performance in Q4 2023, driven by growth in Greater China and a solid financial position. While facing challenges such as currency fluctuations and market-specific issues, the company is well-positioned to capitalize on opportunities through strategic initiatives and market tailoring. By focusing on sustainable growth and innovation, USANA aims to further strengthen its market presence and drive profitability.

USANA Health Sciences reports mixed Q1 results, eyes growth strategies

USANA Health Sciences faced mixed results in Q1 2024, with Mainland China driving growth while other markets struggled. The company is addressing challenges through market-specific incentives and focusing on future strategies like product development and localization.

USANA Health Sciences adapts to market challenges with strategic focus

USANA Health Sciences navigated macroeconomic challenges by implementing strategic initiatives and restructuring its commercial team.
The company's focus on product innovation, market expansion into India, and leadership additions signal a commitment to sustainable success.
While facing challenges in market conditions, USANA aims to leverage opportunities like M&A activities and accelerated product development for growth.

USANA Health Sciences adapts strategies to drive growth amid challenges

USANA Health Sciences faced challenges in Q3 with lower-than-expected net sales, particularly in China, but is implementing strategies to boost performance.
The company's strengths in product innovation, streamlined development processes, and strong product lineup position it well for future growth.
Addressing challenges such as decreased average spend and revised guidance presents opportunities for USANA to enhance revenue and market presence.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

USANA Health Sciences, Inc. (NYSE: USNA) shares slid in the post-market session after it reported preliminary second-quarter results and updated its FY22 outlook. USANA anticipates Q2 net sales will be ~$265 million (compared to $337 million in 2Q21).

USANA Health Sciences Shares Plunge On Q2 Preliminary Results, FY22 Guidance Cut

Usana Health Sciences Inc. shares fell in the extended session Wednesday after the nutritional-supplement sales company lowered its forecast for the year, blaming lockdowns in China for disrupting regional sales programs.

Usana stock drops 10% after China's COVID lockdowns blamed for reduced forecast

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the second quarter ended July 2, 2022, and provided an updated outlook for fiscal year 2022. The Company anticipates that second quarter 2022 net sales will be approximately $265 million, which compares with $337 million in the prior-year period. Earnings per share for the quarter are expected to be approximately $1.05, which compares with $1.87 during the second quarter of 2021. “O

USANA Health Sciences Provides Preliminary Second Quarter Results and Updates Fiscal Year 2022 Outlook

SALT LAKE CITY , July 6, 2022 /PRNewswire/ -- As the world finds its footing with pandemic-induced adjustments, one global CEO and bestselling author is encouraging people everywhere to find peace and lower stress levels on International Peace and Love Day July 7. "Research shows that as we seek peace and show kindness, we reduce stress and become more productive," said Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA).

Kevin Guest Shares 7 Ways to Honor International Peace & Love Day

Symposium in partnership with the US Center for Chinese Medicine SALT LAKE CITY , June 23, 2022 /PRNewswire/ -- Scientific research is vital to a health and wellness company—it spurs continued innovation and development of advanced products for customers. With that goal in mind, USANA recently held a joint research symposium on Traditional Chinese Medicine (TCM) in Maryland in partnership with the US Center for Chinese Medicine (USCCM).

USANA Hosts Joint International Symposium for Traditional Chinese Medicine Research

Honored at Utah Business ' 30 Women to Watch and CXO of the Year Events SALT LAKE CITY , June 22, 2022 /PRNewswire/ -- USANA is proud to announce two members of its legal team were recently recognized as top professionals in their field and Utah's business community by Utah Business magazine. USANA Chief Legal Officer Joshua Foukas was named a CXO of the Year, and USANA Corporate Counsel and Senior Manager of Government Relations Elise Walker Brown was honored as one of Utah's 30 Women to Watch.

USANA Legal Team Brings Home Two Awards

Shares 5 Ways to Lift Moods SALT LAKE CITY , June 21, 2022 /PRNewswire/ -- With the World Day of Music today, one musician-turned-CEO offers five insights for music to lift moods, calm stress, increase harmony and help people get through the day, as more workers return to onsite jobs. "When I was young, I lived music down to my bones, and harmonies played constantly in my head," said Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA).

Kevin Guest Promotes World Day of Music

SALT LAKE CITY , June 1, 2022 /PRNewswire/ -- With the COVID-19 pandemic having eroded corporate culture and upended the rhythm of coworkers' connections, restoring corporate culture may be difficult. One global CEO and bestselling author on harmony outlines steps company leaders should consider to restore a corporate culture that's sustainable.

Kevin Guest Shares 8 Steps to Restore Corporate Culture Post-Pandemic

Becomes Official Nutritional Supplement Supplier of Tall Blacks and Sky Sport Tall Ferns Squads SALT LAKE CITY , May 31, 2022 /PRNewswire/ -- For 30 years USANA, the Cellular Nutrition Company, has been a leader in its industry. With more professional and Olympic athletes trusting USANA with their nutritional needs than any other nutritional supplement in the world, its impressive and diverse roster of athletic partners continues to soar.

USANA Signs Deal with Basketball New Zealand

USANA wins four Best of State Award Medals SALT LAKE CITY , May 31, 2022 /PRNewswire/ -- USANA, a leader in global nutrition, was honored last week at the Best of State Gala in Salt Lake City, Utah for its excellence in product quality and innovation. USANA brought home four awards for Celavive, Rev3, CellSentials, and its Nutritional product line.

Utah Company Brings Home Four Awards from Prestigious Local Organization

SALT LAKE CITY , May 2, 2022 /PRNewswire/ -- With pandemic-induced anxiety and depression levels increasing by 25 percent globally in 2021 and countries scrambling to support citizens' mental health, one CEO is citing five steps for improved outcomes during National Mental Health Month in May. "Some mental health aspects are highly vulnerable to environmental influences, and the pandemic has certainly levied an unprecedented effect on workers," said Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA).

During National Mental Health Month, Bestselling Author/CEO Shares 5 Steps for Harmony, Balance

Soft quarter due to China's Covid surge. We see stock buying opportunity with 65% upside.

USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside

Report highlights USANA's robust sustainability efforts surrounding people, planet, and products SALT LAKE CITY , April 28, 2022 /PRNewswire/ -- As a global company, USANA is acutely aware of the importance of sustainability and the company's role in taking care of the planet and the people who inhabit it. As part of its investment in sustainability, USANA recently released its second annual sustainability report.

USANA Releases 2021 Sustainability Report

USANA Health Sciences, Inc. (NYSE:USNA ) Q1 2022 Results Conference Call April 27, 2022 11:00 AM ET Company Participants Andrew Masuda - Director of Investor Relations Kevin Guest - Chairman and Chief Executive Officer Doug Hekking - Chief Financial Officer Brent Neidig - Chief Officer and Managing Director of China Jim Brown - President Conference Call Participants Chris Neamonitis - Jefferies Doug Lane - Lane Research Linda Bolton Weiser - D.A. Davidson Operator Good day and welcome to USANA Health Sciences' First Quarter Conference Call.

USANA Health Sciences, Inc. (USNA) CEO Kevin Guest on Q1 2022 Results - Earnings Call Transcript

USANA Health (USNA) delivered earnings and revenue surprises of 0.88% and 0.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

USANA Health Sciences (USNA) Beats Q1 Earnings and Revenue Estimates

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended April 2, 2022. Key Financial & Operating Highlights First quarter net sales were $273 million as compared with $308 million during the first quarter of the prior year. First quarter diluted EPS totaled $1.15 versus $1.45 during the first quarter of 2021. Company revises fiscal 2022 net sales and diluted EPS outlook to $1.1 billion to $1.2 billion and

USANA Health Sciences Reports First Quarter Results

USANA Health Sciences (USNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for USANA Health Sciences (USNA) This Earnings Season?

USANA Health (USNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

USANA Health Sciences (USNA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Church & Dwight

Estee Lauder

Helen of Troy

Monster Beverage

In light of consumer prices continuing their record surge in March, five consumer defensive stocks with high GF Scores are The Estee Lauder Companies Inc. ( EL , Financial), Monster Beverage Corp. ( MNST , Financial), Helen of Troy Ltd. ( HELE , Financial), Usana Health Sciences Inc. ( USNA , Financial) and Church & Dwight Co. Inc. ( CHD , Financial) according to the All-in-One Screener, a Premium feature of GuruFocus.

5 Consumer Defensive Stocks With High GF Scores

USANA dubbed a best place to work in direct selling for the fifth time SALT LAKE CITY , April 5, 2022 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in nutrition, was recently recognized as one of the Best Places to Work in Direct Selling by the industry's top publication, Direct Selling News (DSN). It's the fifth time the company has received this recognition in the industry.

Health and Wellness Company Named a Best Place to Work

Bestselling Author, CEO Kevin Guest Shares Insights from Global Leadership SALT LAKE CITY, March 3, 2022 /PRNewswire/ -- Because March 4 is associated with marching forth, it is the perfect date to motivate oneself to achieve goals, says a bestselling author, musician and CEO who inspires leaders around the world. "Successful people do a good job of motivating themselves to take action each day," said Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA), and author of All the Right Reasons, 12 Timeless Principles for Living a Life in Harmony.

Four Steps to March Forth on March 4th

SALT LAKE CITY, Feb. 23, 2022 /PRNewswire/ -- USANA, the Cellular Nutrition Company, proudly sponsors some of the most elite athletes and teams around the globe and celebrates its brand ambassador's and partners' performances during the Winter Games. With 146 athletes from six countries—Canada, Germany, Italy, Mexico, South Korea, and the United States—USANA athletes competed in a dozen disciplines and left Beijing with 21 medals—eight gold, eight silver, and five bronze.

USANA ATHLETES SCORE BIG IN BEIJING WITH 21 MEDALS

USANA: 15x P/E, 14% Net Cash, Stock Repurchases

USANA Health Sciences, Inc.'s (USNA) CEO Kevin Guest on Q4 2021 Results - Earnings Call Transcript

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its full year and fiscal fourth quarter ended January 1, 2022. Key Financial & Operating Highlights Fiscal year 2021 net sales grew 5% to $1.186 billion. Reported fiscal year 2021 diluted EPS totaled $5.73. Fourth quarter net sales reached $267 million and diluted EPS were $1.03. Company provides initial 2022 net sales guidance of $1.125 to $1.225 billion and initial diluted EPS g

News for USANA Health Sciences Stock (USNA)